Latest filing published 03 Aug 2026 for BioPharma Credit PLC, €64.
Anita Hyman appears in our data through filings on BioPharma Credit PLC shares, published by RNS (LSE). Over a trading history stretching from 12 June 2018 to 31 July 2026, the count stands at 25 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 3 August 2026, reports a share grant of €64 in BioPharma Credit PLC. Half of the filings or more reach the RNS (LSE) feed on the day of the trade. The legal deadline for notifying a trade is three business days (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations